Aspira Stock Analysis

AWH
 Stock
  

USD 0.77  0.04  5.48%   

The current bullish price patterns experienced by current Aspira Womans Health shareholders could raise concerns from stockholders as the firm is trading at a share price of 0.77 on 465,920 in volume. The company directors and management have been very successful in rebalancing the firm assets at opportune times to take advantage of market volatility in June. The stock standard deviation of daily returns for 90 days investing horizon is currently 10.83. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Aspira Womans partners.
Please continue to Trending Equities.
  
Refresh
The Aspira Womans stock analysis report makes it easy to digest most publicly released information about Aspira Womans and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Aspira Stock analysis module also helps to analyze the Aspira Womans price relationship with some important fundamental indicators such as market cap and management efficiency.

Aspira Stock Analysis Notes

About 49.0% of the company shares are held by company insiders. The book value of Aspira Womans was presently reported as 0.19. The company recorded a loss per share of 0.31. Aspira Womans Health next dividend is scheduled to be issued on the 16th of December 2016. The entity had 3:1 split on the 4th of March 2008. Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people. For more info on Aspira Womans Health please contact Scott Carmilani at 512 519-0400 or go to www.aspirawh.com.

Aspira Womans Quarterly Cost of Revenue

932,000

Share

Aspira Womans Health Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Aspira Womans' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Aspira Womans Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Aspira Womans Health has very high historical volatility over the last 90 days
Aspira Womans Health has some characteristics of a very speculative penny stock
The company reported the last year's revenue of 7.21 M. Reported Net Loss for the year was (35.01 M) with profit before taxes, overhead, and interest of 3.06 M.
Aspira Womans Health has about 26.86 M in cash with (32.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24.
Aspira Womans Health has a frail financial position based on the latest SEC disclosures
Roughly 49.0% of the company shares are held by company insiders
Latest headline from simplywall.st: Even after rising 18 percent this past week, Aspira Womens Health shareholders are still down 88 percent over the past year - Simply Wall St

Aspira Womans Health Upcoming and Recent Events

Earnings reports are used by Aspira Womans to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aspira Womans previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Aspira Largest EPS Surprises

Earnings surprises can significantly impact Aspira Womans' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-11-08
2018-09-30-0.03-0.04-0.0133 
2018-05-14
2018-03-31-0.04-0.05-0.0125 
2018-03-13
2017-12-31-0.04-0.05-0.0125 
View All Earnings Estimates

Aspira Womans SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Aspira Womans prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Aspira Womans investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Aspira Womans Health specific information freely available to individual and institutional investors to make a timely investment decision.
27th of June 2022
Submission of Matters to a Vote of Security Holders
View
6th of June 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
2nd of June 2022
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
17th of May 2022
Regulation FD Disclosure
View
11th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
23rd of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
28th of February 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
24th of February 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View

Aspira Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aspira Womans is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspira Womans Health backward and forwards among themselves. Aspira Womans' institutional investor refers to the entity that pools money to purchase Aspira Womans' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares4.7 M4.9 M
Vanguard Group IncCommon Shares3.1 M3.2 M
Oracle Investment Management IncCommon Shares2.1 M2.2 M
State Street CorpCommon Shares1.8 M1.9 M
Geode Capital Management LlcCommon Shares1.1 M1.2 M
Renaissance Technologies LlcCommon Shares1.1 M1.2 M
Act Capital Management LlcCommon Shares1000 KM
Note, although Aspira Womans' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aspira Market Capitalization

The company currently falls under 'Micro-Cap' category with total capitalization of 82.18 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aspira Womans's market, we take the total number of its shares issued and multiply it by Aspira Womans's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Aspira Profitablity

Aspira Womans' profitability indicators refer to fundamental financial ratios that showcase Aspira Womans' ability to generate income relative to its revenue or operating costs. If, let's say, Aspira Womans is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aspira Womans' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aspira Womans' profitability requires more research than a typical breakdown of Aspira Womans' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Investment(135.04) (145.70) 
Return on Average Assets(0.61) (0.66) 
Return on Average Equity(0.76) (0.81) 
Return on Invested Capital(57.01) (58.51) 
Return on Sales(4.64) (5.01) 

Management Efficiency

The entity has Return on Asset of (48.25) % which means that on every $100 spent on asset, it lost $48.25. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (94.53) %, meaning that it generated no profit with money invested by stockholders. Aspira Womans management efficiency ratios could be used to measure how well aspira womans health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Investment is estimated to decrease to -145.7. The current Return on Average Assets is estimated to decrease to -0.66. Aspira Womans Total Assets Per Share are most likely to slightly decrease in the upcoming years. The last year's value of Total Assets Per Share was reported at 0.37. The current Asset Turnover is estimated to increase to 0.18, while Total Assets are projected to decrease to roughly 32.6 M.
Last ReportedProjected for 2022
Book Value per Share 0.27  0.30 
Enterprise Value over EBIT(5.00) (5.39) 
Enterprise Value over EBITDA(5.01) (5.41) 
Price to Book Value 6.58  6.75 
Tangible Assets Book Value per Share 0.37  0.42 
Enterprise Value156.7 M148 M
Tangible Asset Value41.1 M32.6 M

Technical Drivers

As of the 5th of July, Aspira Womans shows the mean deviation of 7.5, and Risk Adjusted Performance of (0.003653). Aspira Womans Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to interpolate and break down nineteen technical drivers for Aspira Womans Health, which can be compared to its rivals. Please confirm Aspira Womans Health jensen alpha, as well as the relationship between the potential upside and skewness to decide if Aspira Womans Health is priced correctly, providing market reflects its regular price of 0.77 per share. As Aspira Womans Health is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Aspira Womans Health Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Aspira Womans Health price series.
.

Aspira Womans Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aspira Womans insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aspira Womans' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aspira Womans insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aspira Womans Predictive Daily Indicators

Aspira Womans intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aspira Womans stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Aspira Womans Forecast Models

Aspira Womans time-series forecasting models is one of many Aspira Womans' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aspira Womans' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Aspira Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aspira Womans stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aspira shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Aspira Womans. By using and applying Aspira Stock analysis, traders can create a robust methodology for identifying Aspira entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin(4.59) (4.95) 
Gross Margin 0.45  0.40 
Profit Margin(4.65) (5.01) 
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aspira Womans to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module
Please continue to Trending Equities. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
82.2 M
Quarterly Revenue Growth YOY
0.27
Return On Assets
-0.48
Return On Equity
-0.95
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.